222 related articles for article (PubMed ID: 23074900)
1. Evaluation of antibacterial and anti-biofilm activities of cinchona alkaloid derivatives against Staphylococcus aureus.
Skogman ME; Kujala J; Busygin I; Leinob R; Vuorela PM; Fallarero A
Nat Prod Commun; 2012 Sep; 7(9):1173-6. PubMed ID: 23074900
[TBL] [Abstract][Full Text] [Related]
2. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.
Sauer K; Steczko J; Ash SR
J Antimicrob Chemother; 2009 May; 63(5):937-45. PubMed ID: 19282330
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
Kotulová D; Slobodníková L
Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
[TBL] [Abstract][Full Text] [Related]
5. Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms.
Skogman ME; Vuorela PM; Fallarero A
J Antibiot (Tokyo); 2012 Sep; 65(9):453-9. PubMed ID: 22739537
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus biofilm susceptibility to small and potent β(2,2)-amino acid derivatives.
Ausbacher D; Fallarero A; Kujala J; Määttänen A; Peltonen J; Strøm MB; Vuorela PM
Biofouling; 2014 Jan; 30(1):81-93. PubMed ID: 24256295
[TBL] [Abstract][Full Text] [Related]
7. Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom.
van der Plas MJ; Dambrot C; Dogterom-Ballering HC; Kruithof S; van Dissel JT; Nibbering PH
J Antimicrob Chemother; 2010 May; 65(5):917-23. PubMed ID: 20189943
[TBL] [Abstract][Full Text] [Related]
8. Control of bacterial biofilms with marine alkaloid derivatives.
Huigens RW; Ma L; Gambino C; Moeller PD; Basso A; Cavanagh J; Wozniak DJ; Melander C
Mol Biosyst; 2008 Jun; 4(6):614-21. PubMed ID: 18493660
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms.
Bakkiyaraj D; Pandian SK
Biofouling; 2010 Aug; 26(6):711-7. PubMed ID: 20706890
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of branch extracts of Juniperus species from Turkey on Staphylococcus aureus biofilm.
Marino A; Bellinghieri V; Nostro A; Miceli N; Taviano MF; Güvenç A; Bisignano G
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):470-6. PubMed ID: 20584079
[TBL] [Abstract][Full Text] [Related]
11. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
12. Extracellular protease in Actinomycetes culture supernatants inhibits and detaches Staphylococcus aureus biofilm formation.
Park JH; Lee JH; Kim CJ; Lee JC; Cho MH; Lee J
Biotechnol Lett; 2012 Apr; 34(4):655-61. PubMed ID: 22160331
[TBL] [Abstract][Full Text] [Related]
13. 3-Amino-4-aminoximidofurazan derivatives: small molecules possessing antimicrobial and antibiofilm activity against Staphylococcus aureus and Pseudomonas aeruginosa.
Das MC; Paul S; Gupta P; Tribedi P; Sarkar S; Manna D; Bhattacharjee S
J Appl Microbiol; 2016 Apr; 120(4):842-59. PubMed ID: 26785169
[TBL] [Abstract][Full Text] [Related]
14. Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
Schito AM; Piatti G; Stauder M; Bisio A; Giacomelli E; Romussi G; Pruzzo C
Int J Antimicrob Agents; 2011 Feb; 37(2):129-34. PubMed ID: 21163629
[TBL] [Abstract][Full Text] [Related]
15. Pyrrolomycins as potential anti-staphylococcal biofilms agents.
Schillaci D; Petruso S; Raimondi MV; Cusimano MG; Cascioferro S; Scalisi M; La Giglia MA; Vitale M
Biofouling; 2010; 26(4):433-8. PubMed ID: 20234952
[TBL] [Abstract][Full Text] [Related]
16. Automating a 96-well microtitre plate model for Staphylococcus aureus biofilms: an approach to screening of natural antimicrobial compounds.
Sandberg M; Määttänen A; Peltonen J; Vuorela PM; Fallarero A
Int J Antimicrob Agents; 2008 Sep; 32(3):233-40. PubMed ID: 18640013
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Acinetobacter baumannii, Staphylococcus aureus and Pseudomonas aeruginosa biofilm formation with a class of TAGE-triazole conjugates.
Huigens RW; Rogers SA; Steinhauer AT; Melander C
Org Biomol Chem; 2009 Feb; 7(4):794-802. PubMed ID: 19194596
[TBL] [Abstract][Full Text] [Related]
18. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
Mirani ZA; Jamil N
J Basic Microbiol; 2011 Apr; 51(2):191-5. PubMed ID: 20967790
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.
McConeghy KW; LaPlante KL
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):1-6. PubMed ID: 20727462
[TBL] [Abstract][Full Text] [Related]
20. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
Gupta S; Agarwal S; Sahoo DR; Muralidharan S
Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
